share_log

BioNTech | 6-K: Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union

BioNTech | 6-K: Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union

BioNTech | 6-K:輝瑞和BioNTech在歐盟獲得CHMP對改編Omicron KP.2的COVID-19疫苗的積極評價
美股SEC公告 ·  09/20 09:22
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息